Costs remain a problem in growing Chinese stent market
This article was originally published in Clinica
Executive Summary
China's market for cardiovascular stents is outgrowing interventional cardiology procedures, according to a Frost & Sullivan report. However, the high expense of stents, rogue practices and fatalities associated with materials used in stents, recently uncovered in the US, are having a negative effect on the sector.